We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRC icon
176
Ameresco
AMRC
$994M
$15.4M 0.11%
399,883
+1
+0% +$48
IDXX icon
177
Idexx Laboratories
IDXX
$45.4B
$15.4M 0.11%
35,235
+29,154
+479% +$14.5M
GPK icon
178
Graphic Packaging
GPK
$3.44B
$15.2M 0.11%
683,351
-75,326
-10% -$1.73M
BLD
179
DELISTED
TopBuild
BLD
$15.2M 0.11%
60,456
-19,451
-24% -$5.36M
IMCR icon
180
Immunocore
IMCR
$1.71B
$15.2M 0.11%
293,011
-57,003
-16% -$3.37M
CYTK icon
181
Cytokinetics
CYTK
$10.9B
$14.8M 0.11%
503,240
-35,000
-7% -$1.17M
MAR icon
182
Marriott International
MAR
$100B
$14.8M 0.1%
75,068
-12,669
-14% -$2.52M
ADI icon
183
Analog Devices
ADI
$179B
$14.6M 0.1%
83,464
-146,878
-64% -$27.1M
DGX icon
184
Quest Diagnostics
DGX
$26.4B
$14.6M 0.1%
119,722
+17,919
+18% +$2.39M
GH icon
185
Guardant Health
GH
$19.1B
$14.6M 0.1%
491,137
-68,225
-12% -$2.4M
FSLR icon
186
First Solar
FSLR
$21.2B
$14.3M 0.1%
88,673
-1,998
-2% -$373K
ACLX
187
DELISTED
Arcellx
ACLX
$14.3M 0.1%
398,020
– –
MTZ icon
188
MasTec
MTZ
$24.3B
$14M 0.1%
193,964
-207,034
-52% -$20.6M
ICE icon
189
Intercontinental Exchange
ICE
$85.8B
$13.9M 0.1%
126,460
+13,399
+12% +$1.54M
BSY icon
190
Bentley Systems
BSY
$10.8B
$13.7M 0.1%
272,168
+71,108
+35% +$3.58M
CRNC icon
191
Cerence
CRNC
$357M
$13.6M 0.1%
668,402
-3,690
-0.5% -$92.8K
UDR icon
192
UDR
UDR
$12.8B
$13.4M 0.1%
376,937
-417,205
-53% -$16.6M
CCK icon
193
Crown Holdings
CCK
$13.2B
$13.4M 0.1%
151,859
– –
EA icon
194
Electronic Arts
EA
$52.5B
$13.2M 0.09%
109,697
+1,006
+0.9% +$127K
XNCR icon
195
Xencor
XNCR
$1.44B
$13.2M 0.09%
652,984
– –
WMT icon
196
Walmart Inc
WMT
$917B
$13.1M 0.09%
245,511
-9,735
-4% -$518K
ASND icon
197
Ascendis Pharma A/S
ASND
$16.4B
$13.1M 0.09%
139,375
-9,000
-6% -$842K
NFLX icon
198
Netflix
NFLX
$307B
$13M 0.09%
345,370
-99,790
-22% -$4.23M
DOV icon
199
Dover
DOV
$27.8B
$13M 0.09%
93,053
+3,166
+4% +$457K
NTRA icon
200
Natera
NTRA
$36B
$12.8M 0.09%
289,990
-15,024
-5% -$766K
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.